Quest Diagnostics Inc. 2026 Global Healthcare Conference

Hey. Good morning, everyone. My name is Eric Coldwell. It's really a great pleasure to have Quest Diagnostics with us here today. Jim has been incredibly gracious over the last couple of years. Last few years now, I guess. Where are we? Time runs together.

Year four. Gosh. Hard to believe.

We knew each other for a long time before that, though.

We did. Really gracious with his time.

Great leadership example at the company. The performance at Quest Diagnostics has been exceptionally strong the last few years, and it has been a lot of fun covering this space, which used to be a bit of a stable, but maybe some would say boring industry. There is not much boring to it anymore.

Yeah. Boring with good results. Stable and good growth. Yep.

Of course, Jim, President and CEO. We have Dominic and Dan still gracing us from the IR team here. Dan, I bet you can't wait to go on to new pastures, and Dominic's getting up to speed quickly. We're not going to do a slideshow. We're going to jump straight into Q&A, but I don't know if you have 30 seconds of prepared remarks or even want to go off the cuff, or I can just jump.

Awesome. Thanks. All right. Well, I wanted to tee this up or start this off with a bit of a report card.

You had an investor day couple of years back, and you laid out some long range plans, and you've done incredibly well versus those plans, tracking very nicely. But how you're getting there is a little different than what was set up, how this was staged. For example, I believe the original target was $1.5 billion of M&A, and you've done maybe a couple of hundred million of M&A two-thirds of the way through.

Yeah What really happened or changed versus that, if you can set yourself back in time, versus that original LRP, the plan to get more of your growth through M&A, to spend more on M&A.